2003 Article Views
Publication Date: 30 Oct 2008
Journal: Clinical Medicine Insights: Pathology Clinical Medicine: Pathology 2008:1 105-113
Abstract Salvatore Docimo, Jr.1,4, Carmen Piccolo2, Daniel Van Arsdale3 and David E. Elkowitz4
1Academic Medicine Fellow, Department of Pathology, New York College of Osteopathic Medicine, Old Westbury, NY. 2Resident, Department of Surgery, Philadelphia College of Osteopathic Medicine, Philadelphia, PA. 3Department of Osteopathic Manipulative Medicine, New York College of Osteopathic Medicine, Old Westbury, NY. 4Department of Pathology, New York College of Osteopathic Medicine, Old Westbury, NY.
Abstract
Sympathetic hyperinnervation due to nerve sprouting generated by the left stellate ganglion has been noted following cardiopulmonary disease processes. Sympathetic hyperinnervation seems to be limited to cardiopulmonary diseases in the experimental and clinical settings. However, histological changes of the left stellate ganglion following cardiopulmonary diseases in humans have yet to be observed. This study intends to investigate the histological changes of cadaveric sympathetic nervous tissue of left stellate ganglia (n = 32) and their relationship to noted pathology. Our study found fibrotic changes of the left stellate ganglion are not significantly dependent upon pathological processes, however, changes in the number of nerve cell bodies seems to be pathology dependent. A relationship between respiratory (mean = 33.3; P = 0.023) and cardiovascular pathologies (mean = 29.6; P = 0.199) and an increase in nerve cell bodies of the left stellate ganglion was noted when compared to other pathologies (mean = 25.7). The link between cardiopulmonary disease and sympathetic hyperinnervation may be the increase in the number of nerve cell bodies of the left stellate ganglion. Our results are clinically significant considering sympathetic hyperinnervation is associated with arrythmogenesis and an increase in morbidity and mortality in patients with pulmonary disease. Such findings may warrant investigation into the use of ganglion blockade in cardiopulmonary diseases.
Discussion
No comments yet...Be the first to comment.
I had an excellent experience publishing our review article in Clinical Medicine Reviews. The managing editor was very helpful and the process was very timely and transparent.Professor Jonathan A. Bernstein (University of Cincinnati College of Medicine, Division of Immunology, Allergy Section, Cincinnati, OH, USA) What our authors say
Copyright © 2010 Libertas Academica Ltd (except open access articles and accompanying metadata and supplementary files.)